The new HealthVerity: View from the Curisium CEO
Last week, HealthVerity announced its acquisition of Curisium, an innovator in cloud-based drug...
Last week, HealthVerity announced its acquisition of Curisium, an innovator in cloud-based drug...
This week’s webinar, VBA 2.0 Building and accelerating VBA for the next era, offered a deeper look...
Value-based agreements unite pharma companies and payers with a mutually beneficial payment model,...
Throughout the past quarter, we’ve announced major collaborations, built on existing partnerships...
The COVID-19 outbreak has created an unprecedented need for real-time data. As the global pandemic...
The coronavirus pandemic continues to be a disruptive force for patients and physicians across the...
Healthcare has the lowest digital ad spend among major industries today. Privacy protection laws...
Rare diseases may be individually uncommon, but collectively they affect an estimated 30 million people in the United States. Yet for many patients, the path to diagnosis spans years, sometimes decades. Symptoms appear one at a time. Specialists trea...